Malignancy risk in patients with giant cell arteritis: A population-based cohort study

Arthritis Care and Research

Volumn 62, Issue 2, 2010, Pages 149-154

  Kermani, Tanaz A ^a   Schäfer, Valentin S ^a   Crowson, Cynthia S ^a   Hunder, Gene G ^a   Gabriel, Sherine E ^a   Ytterberg, Steven R ^a   Matteson, Eric L ^a   Warrington, Kenneth J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CIGARETTE SMOKING; COLON CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; SOLID TUMOR;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; MALE; NEOPLASMS; RISK ASSESSMENT;

EID: 75749111003     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20062     Document Type: Article

References (25)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372:234-45.
2. Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Opin Rheumatol 1997;9:3-11.
3. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 2007;120: 435-46.
4. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999;108:1-7.
5. Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 2002;21:309-13.
6. Lie JT. Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. J Rheumatol 1995;22:367-9.
7. Warrington KJ, Scheithauer BW, Michet CJ. Acute myeloid leukemia associated with necrotizing temporal arteritis. J Rheumatol 2003;30:846-8.
8. Solans-Laque R, Bosch-Gil JA, Perez-Bocanegra C, Selva-O'Callaghan A, Simeon-Aznar CP, Vilardell-Tarres M. Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 2008;35:294-304.
9. Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, Pena-Sagredo JL, Lopez-Agreda H, Miranda-Filloy JA, et al. Cancer in biopsy-proven giant cell arteritis: a population-based study. Semin Arthritis Rheum 2007;37:156-63.
10. Liozon E, Loustaud V, Fauchais AL, Soria P, Ly K, Ouattara B, et al. Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature. J Rheumatol 2006;33:1606-14.
11. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993;20:1335-9.
12. Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis: a prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 2002;29:2143-7.
13. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
14. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004;30:819-34.
15. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-8.
16. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 2009. E-pub ahead of print.
17. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
18. Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore DM, McDonnell SK, et al. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord 2005;20:719-25.
19. Elbaz A, Peterson BJ, Yang P, van Gerpen JA, Bower JH, Maraganore DM, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 2002;13:157-64.
20. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291:585-90.
21. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 2008; 123:1133-40.
22. Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 2006;42:704-7.
23. Larsson K, Mellstrom D, Nordborg E, Oden A, Nordborg E. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis 2006;65:529-32.
24. Duhaut P, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J, et al, for the Recherche sur L'Artérite à Cellules Géantes. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Arthritis Rheum 1998;41:1960-5.
25. Machado EB, Gabriel SE, Beard CM, Michet CJ, O'Fallon WM, Ballard DJ. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989; 18:836-41.